TORONTO & SAN FRANCISCO, February 14, 2024 Treadwell Therapeutics, a privately held clinical-stage biotechnology company pioneering and advancing novel first-in-class medicines for unmet needs in cancer, today announced the formation of a Scientific Advisory Board comprised of prominent oncology leaders and drug developers. The SAB will work closely with Treadwell to advance the company’s pipeline of small molecules, biologics and cell therapies.
COVID vaccine developers among Technion Harvey Prize recipients ynetnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ynetnews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Synendos Therapeutics (Synendos), a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to.
/PRNewswire/ Synendos Therapeutics (Synendos), a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to.